in

YES! LOVE

Tom Cotton: America Has A Plan To Take Industry BACK From China, Especially Pharma

Sen. Tom Cotton (R., Ark.) introduced legislation Thursday to repatriate pharmaceutical manufacturing from China to America, aiming to reduce a dependency that could seriously limit the U.S. coronavirus response.

The bill, which Cotton introduced with Rep. Mike Gallagher (R., Wis.), aims to severely curtail the volume of Chinese active pharmaceutical ingredients (APIs) from the U.S. medical drug supply. The PRC currently produces most of the world’s APIs—the “active ingredients” in commonly used drugs—leaving the United States and other nations critically dependent on it for medicines.

Cotton’s is just the latest proposal to onshore pharmaceutical supply chains, including a similar one from Sen. Marco Rubio (R., Fla.) and rumblings from the White House about a “buy American” executive order. Prompted by the coronavirus pandemic, many are beginning to see the cost-savings from Chinese-made pharmaceuticals as not worth the risk of undersupply during another pandemic, or during a potential conflict with America’s main geostrategic rival.

“China unleashed this plague on the world, and China has to be held accountable,” said Cotton during a Fox News interview Wednesday evening. “It’s too grave a threat to let our health rest on Chinese drugs.” – READ MORE

What do you think?

16 points
Upvote Downvote

Total votes: 16

Upvotes: 16

Upvotes percentage: 100.000000%

Downvotes: 0

Downvotes percentage: 0.000000%

2 Comments

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

PA Governor Takes Corona Shut Down TOO FAR – Uses Police To FORCE Businesses Closed

Report: AG Barr Is Attempting A MAJOR Overreach Of Power Amidst Coronavirus Outbreak